Epigral Reports Record Operating Profit Amid Mixed Financial Indicators for December Quarter

Epigral, a midcap player in the chemicals industry, has recently reported its financial results for the quarter ending December 2024. The company has experienced notable developments in its financial metrics, leading to an adjustment in its evaluation. The score has shifted to 18 from 10 over the past three months, reflecting a significant change in assessment.
Key highlights from Epigral's financial performance include a record operating profit of Rs 182.51 crore, marking consistent growth over the last five quarters. The profit after tax (PAT) also reached Rs 103.63 crore, showing a substantial increase compared to the average PAT of the previous four quarters. Additionally, net sales for the half-year stood at Rs 1,271.30 crore, indicating a year-on-year growth of 33.87%.

However, not all aspects are favorable. The operating profit to interest ratio has reached a low of -2,607.29 times, suggesting challenges in managing interest payments. Furthermore, cash and cash equivalents have decreased to Rs 6.08 crore, indicating a decline in short-term liquidity. The debtors turnover ratio has also slowed, reflecting a longer time frame in settling debts.

For more insights on Epigral's financial trends, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.